New research from Sylvester Comprehensive Cancer Center indicates that providing prophylactic treatment before immunotherapy can significantly reduce the rate o
Ten abstracts, including three oral presentations, spotlight the expanding body of evidence supporting odronextamab in follicular lymphoma and diffuse.
Ten abstracts, including three oral presentations, spotlight the expanding body of evidence supporting odronextamab in follicular lymphoma and diffuse large B-cell lymphoma Additional presentations.